China Pharma Hlgs (CPHI) Stock
Very small pharmaceutical company with limited public information. Here's the price, business snapshot, and what's worth knowing about China Pharma Hlgs in July 2026.
China Pharma Holdings Inc (ticker: CPHI) is a very small-capitalisation pharmaceutical company with a market value of about $5.84 million. Publicly available information on its operations, product pipeline and revenue is limited, which is common among micro-cap firms. Such companies may be involved in manufacturing, generics or early-stage research, but specifics can vary and should be confirmed from primary filings. Micro-cap status typically means low trading volumes, greater price volatility and heightened sensitivity to operational, regulatory and currency risks. Corporate governance and transparency may also differ from larger peers. Investors interested in CPHI should review regulatory filings, audited accounts and company announcements and consider liquidity constraints. For most portfolios, exposure to a micro-cap pharmaceutical is speculative and should be small relative to overall holdings. This summary is educational only and not personalised advice; values can fall as well as rise and returns are not guaranteed.
Stock Performance Snapshot
Financial Health
China Pharma Holdings is generating modest revenue and cash flow, indicating stable but limited financial growth.
View more stocks by downloading the app for FREE
It only takes 60 seconds.
Baskets Featuring CPHI
China Export Stocks: Could They Drive Growth?
China's economy is leaning on its powerful export sector to meet growth targets amidst falling domestic consumption. This theme identifies the key Chinese industrial and manufacturing companies that are benefiting from a record trade surplus and successful market diversification.
Published: 21 January 2026
Explore BasketChina Export Stocks | Record Trade Surplus Growth
China's economy met its annual growth target, but this was driven by a record trade surplus rather than internal spending. This creates an opportunity to invest in the export-oriented industrial companies that are powering through the domestic slowdown.
Published: 20 January 2026
Explore BasketSupply Chain Reshoring Investment Theme Explained
In response to Chinese export controls, the US announced a 100% tariff on all Chinese imports, escalating the trade war. This creates a potential investment opportunity in American companies poised to benefit from the reshoring of manufacturing and supply chains.
Published: 11 October 2025
Explore BasketU.S.-China Trade Truce | Investment Opportunities
High-level talks between the U.S. and China are underway to prevent the return of tariffs, a critical step for global economic stability. This creates a potential investment opportunity in companies poised to benefit from improved trade relations and the removal of trade barriers.
Published: 15 September 2025
Explore BasketChina's Biopharma Innovators: The Next Global Partnership Wave
Following GSK's major licensing deal with China's Jiangsu Hengrui, a new investment theme is emerging around Chinese pharmaceutical innovators. This theme focuses on other Chinese biopharma companies that are likely to attract similar global partnerships, driving value through their advanced drug development pipelines.
Published: 28 July 2025
Explore BasketWhy You’ll Want to Watch This Stock
Micro-cap market dynamics
Low market capitalisation often leads to pronounced price swings and limited liquidity; investors should be prepared for higher volatility.
China exposure factors
Regulatory, currency and reporting environments in China can materially affect performance, so review cross-border risks and disclosures carefully.
Sector specifics to watch
Pipeline updates, approvals or partnerships can move the share price significantly, though outcomes are uncertain and subject to regulatory review.
Why invest with Nemo?
Zero Commission
Trade stocks, ETFs, and more with zero commission. Keep more of your returns.
Trusted & Regulated
Part of Exinity Group 2015, serving over a million customers globally.
6% Interest on Cash
Earn 6% AER on uninvested cash with daily interest payments.
